The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The CXC Chemokines IP-10 and Mig Are Necessary for IL-12-Mediated Regression of the Mouse RENCA Tumor
Open accessAbstract
The role of the non-ELR-containing CXC chemokines IP-10 and Mig in antitumor activity induced by systemic treatment with IL-12 was examined in mice bearing the murine renal adenocarcinoma RENCA. IL-12 treatment produces a potent antitumor effect that is associated with tumor infiltration by CD8+ T lymphocytes. The regression of tumor is associated with the elevated expression of the IFN-γ-inducible chemokines IP-10 and Mig within the tumor tissue. IP-10 and Mig have been shown to function as chemoattractants for activated T lymphocytes. In animals treated with rabbit polyclonal Abs specific for IP-10 and for Mig, the IL-12-induced regression of RENCA tumors was partially abrogated. This effect was associated with a dramatic inhibition of T cell infiltration. Thus, it appears that IL-12-dependent, T cell-mediated antitumor activity requires the intermediate expression of IP-10 and Mig to recruit antitumor effector T cells to the tumor site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., & Romagnani, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1199 · Cited by 1,665
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1223 · Cited by 1,197
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Interleukin-12 and its role in the generation of TH1 cells
Trinchieri, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90230-i · Cited by 845
Recombinant IL-12 administration induces tumor regression in association with IFN- gamma production.
Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1697 · Cited by 780
Mig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., & Oppenheim, J. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1809 · Cited by 752
Inhibition of Angiogenesis In Vivo by Interleukin 12
Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., & Folkman, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.8.581 · Cited by 722
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
Sgadari, C., Angiolillo, A., & Tosato, G. (1996) · Blood · doi:10.1182/blood.v87.9.3877.bloodjournal8793877 · Cited by 469
Luster, A. D., Greenberg, S. M., & Leder, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.219 · Cited by 446
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
Luster, A. D., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1057 · Cited by 407
Interleukin-8 and the chemokine family
Baggiolini, M., Loetscher, P., & Moser, B. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)00088-6 · Cited by 400
Human Mig chemokine: biochemical and functional characterization.
Liao, F., Rabin, R. L., Yannelli, J. R., Koniaris, L. G., Vanguri, P., & Farber, J. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1301 · Cited by 373
Structure-activity relationships of chemokines
Clark-Lewis, I., Kim, K.-S., Rajarathnam, K., Gong, J.-H., Dewald, B., Moser, B., Baggiolini, M., & Sykes, B. D. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.703 · Cited by 361
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
Rothenberg, M. E., Luster, A. D., & Leder, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8960 · Cited by 345
Farber, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5238 · Cited by 298
Brunda, M. J. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.2.280 · Cited by 295
A Central Role of Perforin in Cytolysis?
Podack, E. R., Hengartner, H., & Lichtenheld, M. G. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001021 · Cited by 280
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., & Kunkel, S. L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.752 · Cited by 250
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Ozmen, L., Pericin, M., Hakimi, J., Chizzonite, R. A., Wysocka, M., Trinchieri, G., Gately, M., & Garotta, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.907 · Cited by 229
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
Rollins, B. J., & Sunday, M. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3125 · Cited by 217
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
Sgadari, C., Angiolillo, A. L., Cherney, B. W., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N., Gupta, G., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13791 · Cited by 217
The role of interleukin 12 in the immune response, disease and therapy
Trinchieri, G., & Scott, P. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90189-9 · Cited by 217
Lowin, B., Beermann, F., Schmidt, A., & Tschopp, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11571 · Cited by 214
Combined chemokine and cytokine gene transfer enhances antitumor immunity
Dilloo, D., Bacon, K., Holden, W., Zhong, W., Burdach, S., Zlotnik, A., & Brenner, M. (1996) · Nature Medicine · doi:10.1038/nm1096-1090 · Cited by 209
Orange, J. S., Salazar-Mather, T. P., Opal, S. M., Spencer, R. L., Miller, A. H., McEwen, B. S., & Biron, C. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.901 · Cited by 207
Clark-Lewis, I., Dewald, B., Loetscher, M., Moser, B., & Baggiolini, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33975-3 · Cited by 180
Role of Interferon-γ in Mediating the Antitumor Efficacy of Interleukin-12
Brunda, M. J., Luistro, L., Hendrzak, J. A., Fountoulakis, M., Garotta, G., & Gately, M. K. (1995) · Journal of Immunotherapy · doi:10.1097/00002371-199502000-00001 · Cited by 164
Interleukin-12. Biologic activity, therapeutic utility, and role in disease.
Hendrzak, J. A., & Brunda, M. J. (1995) · PubMed · Cited by 163
Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12
Tannenbaum, C. S., Wicker, N. B., Armstrong, D., Tubbs, R., Finke, J. H., Bukowski, R. M., & Hamilton, T. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.693 · Cited by 155
Self-citationAlexander, J. P., Kudoh, S., Melsop, K. A., Hamilton, T. A., Edinger, M. G., Tubbs, R. R., Sica, D., Tuason, L. J., Klein, E. A., & Bukowski, R. M. (1993) · PubMed · Cited by 153
Self-citationEnzyme immunohistochemistry: technical aspects.
Sheibani, K., & Tubbs, R. R. (1984) · PubMed · Cited by 148
Self-citationMulé, J. J., Custer, M. C., Averbook, B. J., Yang, J. C.-H., Weber, J. S., Goeddel, D. V., Rosenberg, S. A., & Schall, T. J. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.13-1545 · Cited by 135
Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.
Salcedo, T. W., Azzoni, L., Wolf, S. F., & Perussia, B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2511 · Cited by 124
Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells
Huang, S., Singh, R. K., Xie, K., Gutman, M., Berry, K. K., Bucana, C. D., Fidler, I. J., & Bar‐Eli, M. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01525986 · Cited by 95
Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano, A., Visonneau, S., Clark, S. C., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.6.2943 · Cited by 92
Characterization of lipopolysaccharide-induced macrophage gene expression.
Tannenbaum, C. S., Koerner, T. J., Jansen, M. M., & Hamilton, T. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3640 · Cited by 89
Self-citationInhibition of in vivo tumor growth by the beta chemokine, TCA3.
Laning, J. C., Kawasaki, H., Tanaka, E., Luo, Y., & Dorf, M. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4625 · Cited by 82
Cancer Immunotherapy: are the Results Discouraging? Can They be Improved?
Kedar, E., & Klein, E. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60308-5 · Cited by 74
Manome, Y., Wen, P. Y., Hershowitz, A., Tanaka, T., Rollins, B. J., Kufe, D. W., & Fine, H. A. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01516997 · Cited by 63
Hamilton, T. A., Bredon, N., Ohmori, Y., & Tannenbaum, C. S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.7.2325 · Cited by 60
Self-citationHUANG, S., Xie, K., Singh, R. K., Gutman, M., & Bar‐Eli, M. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.655 · Cited by 36
Cited by
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.007 · Cited by 1,627
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
(2000) · PubMed · Cited by 706
Metadata
- Authors
- Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., & Hamilton, T. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-07
- Volume
- 161
- Issue
- 2
- Pages
- 927-932
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1521747187
- Cited by
- 294
- References
- 52
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.